Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2016

Open Access 01-12-2016 | Case report

Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis

Authors: George Giannakoulas, Panagiotis Savvoulidis, Vasilios Grosomanidis, Sophia-Anastasia Mouratoglou, Haralambos Karvounis, Stavros Hadjimiltiades

Published in: BMC Pulmonary Medicine | Issue 1/2016

Login to get access

Abstract

Background

Neurofibromatosis type 1 (NF1) is a rare multisystem genetic disorder. During the course of the disease it can be rarely complicated with pulmonary hypertension (PH) which confers a dismal prognosis.

Case presentation

We describe the case of a 57-year-old female patient with NF1 complicated by severe precapillary PH despite dual disease-specific oral combination therapy. The patient was treated with initial atrial septostomy followed by administration of high-dose subcutaneous treprostinil with a favorable medium-term clinical and hemodynamic response.

Conclusions

PH secondary to NF1 may be successfully treated with the combination of atrial septostomy and PH targeted therapy in selected patients.
Literature
2.
go back to reference Gutmann DH, Collins FS. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron. 1993;10:335–43.CrossRefPubMed Gutmann DH, Collins FS. The neurofibromatosis type 1 gene and its protein product, neurofibromin. Neuron. 1993;10:335–43.CrossRefPubMed
3.
go back to reference Stewart DR, Cogan JD, Kramer MR, et al. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? Chest. 2007;132:798–808.CrossRefPubMed Stewart DR, Cogan JD, Kramer MR, et al. Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? Chest. 2007;132:798–808.CrossRefPubMed
4.
go back to reference Montani D, Coulet F, Girerd B, et al. Pulmonary hypertension in patients with Neurofibromatosis type 1. Med. 2011;90:201–10.CrossRef Montani D, Coulet F, Girerd B, et al. Pulmonary hypertension in patients with Neurofibromatosis type 1. Med. 2011;90:201–10.CrossRef
5.
go back to reference Hamilton SJ, Friedman JM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet. 2000;58:341–4.CrossRefPubMed Hamilton SJ, Friedman JM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet. 2000;58:341–4.CrossRefPubMed
6.
go back to reference Koeken Y, Kuijpers NH, Lumens J, Arts T, Delhaas T. Atrial septostomy benefits severe pulmonary hypertension patients by increase of left ventricular preload reserve. Am J Physiol Heart Circ Physiol. 2012;302:2654–62.CrossRef Koeken Y, Kuijpers NH, Lumens J, Arts T, Delhaas T. Atrial septostomy benefits severe pulmonary hypertension patients by increase of left ventricular preload reserve. Am J Physiol Heart Circ Physiol. 2012;302:2654–62.CrossRef
7.
go back to reference Kamdar F, Thenappan T, Missov E. Pulmonary arterial hypertension in von Recklinghausen’s disease. Am J Med. 2015;128:39–40.CrossRef Kamdar F, Thenappan T, Missov E. Pulmonary arterial hypertension in von Recklinghausen’s disease. Am J Med. 2015;128:39–40.CrossRef
8.
go back to reference Engel PJ, Baughman RP, Menon SG, Kereiakes DJ, Taylor L, Scott M. Pulmonary hypertension in neurofibromatosis. Am J Cardiol. 2007;99:1177–8.CrossRefPubMed Engel PJ, Baughman RP, Menon SG, Kereiakes DJ, Taylor L, Scott M. Pulmonary hypertension in neurofibromatosis. Am J Cardiol. 2007;99:1177–8.CrossRefPubMed
9.
go back to reference Tamura Y, Ono T, Sano M, Fukuda K, Kataoka M, Satoh T. Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension. Am J Respir Crit Care Med. 2012;186:291–2.CrossRefPubMed Tamura Y, Ono T, Sano M, Fukuda K, Kataoka M, Satoh T. Favorable effect of sorafenib in a patient with neurofibromatosis-associated pulmonary hypertension. Am J Respir Crit Care Med. 2012;186:291–2.CrossRefPubMed
10.
go back to reference Uusitalo E, Rantanen M, Kallionpää RA, et al. Distinctive cancer associations in patients with neurofibromatosis type I. J Clin Oncol. 2016;34:1978–86.CrossRefPubMed Uusitalo E, Rantanen M, Kallionpää RA, et al. Distinctive cancer associations in patients with neurofibromatosis type I. J Clin Oncol. 2016;34:1978–86.CrossRefPubMed
Metadata
Title
Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis
Authors
George Giannakoulas
Panagiotis Savvoulidis
Vasilios Grosomanidis
Sophia-Anastasia Mouratoglou
Haralambos Karvounis
Stavros Hadjimiltiades
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2016
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-016-0337-7

Other articles of this Issue 1/2016

BMC Pulmonary Medicine 1/2016 Go to the issue